Type of RNA Packed in VLPs Impacts IgG Class Switching—Implications for an Influenza Vaccine Design

RNA and Toll-Like Receptor 7 License the Generation of Superior Secondary Plasma Cells at Multiple Levels in a B Cell Intrinsic Fashion

(2019) Caroline C. Krueger et al.   Frontiers in Immunology

Retrovirus-Based Virus-Like Particle Immunogenicity and Its Modulation by Toll-Like Receptor Activation

(2017) Fabien Pitoiset et al.   JOURNAL OF VIROLOGY

Cross-Protective Efficacy of Influenza Virus M2e Containing Virus-Like Particles Is Superior to Hemagglutinin Vaccines and Variable Depending on the Genetic Backgrounds of Mice

(2017) Yu-Jin Kim et al.   Frontiers in Immunology

Cutting Edge: B Cell–Intrinsic T-bet Expression Is Required To Control Chronic Viral Infection

(2016) Burton E. Barnett et al.   JOURNAL OF IMMUNOLOGY

Mechanisms of Virus Assembly

(2015) Jason D. Perlmutter et al.   Annual Review of Physical Chemistry

MAVS, cGAS, and endogenous retroviruses in T-independent B cell responses

(2014) Ming Zeng et al.   SCIENCE

Enhanced Neutralizing Antibody Titers and Th1 Polarization from a Novel Escherichia coli Derived Pandemic Influenza Vaccine

(2013) David A. G. Skibinski et al.   PLoS One

Universal vaccine against influenza virus: Linking TLR signaling to anti-viral protection

(2012) Nicole Schmitz et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

IFN type I and type II independent enhancement of B cell TLR7 expression by natural killer cells

(2012) Suwan Sinha et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Selective Utilization of Toll-like Receptor and MyD88 Signaling in B Cells for Enhancement of the Antiviral Germinal Center Response

(2011) Baidong Hou et al.   IMMUNITY

VISA Is Required for B Cell Expression of TLR7

(2011) L.-G. Xu et al.   JOURNAL OF IMMUNOLOGY

Superior Immunogenicity of Inactivated Whole Virus H5N1 Influenza Vaccine is Primarily Controlled by Toll-like Receptor Signalling

(2011) Felix Geeraedts et al.   PLoS Pathogens

Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection

(2010) K. El Bakkouri et al.   JOURNAL OF IMMUNOLOGY

A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice

(2010) Gunther Spohn et al.   Virology Journal

BCR-mediated uptake of antigen linked to TLR9 ligand stimulates B-cell proliferation and antigen-specific plasma cell formation

(2009) J. Eckl-Dorna et al.   BLOOD

Sequences derived from self-RNA containing certain natural modifications act as suppressors of RNA-mediated inflammatory immune responses

(2009) S. Tluk et al.   INTERNATIONAL IMMUNOLOGY

AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity

(2009) A. M. Didierlaurent et al.   JOURNAL OF IMMUNOLOGY

The coming of age of virus-like particle vaccines

(2008) Gary T. Jennings et al.   BIOLOGICAL CHEMISTRY